We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Alexion Pharmaceuticals Inc | NASDAQ:ALXN | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 182.50 | 183.00 | 185.00 | 0 | 01:00:00 |
From May 2019 to May 2024
By Colin Kellaher
Alexion Pharmaceuticals Inc. (ALXN) on Wednesday said its board authorized the repurchase of up to $1 billion in stock.
The Boston biopharmaceutical company said it has no obligation to buy back any particular number of shares under the program, which has no expiration date.
Alexion, which has about 224 million shares outstanding, sports a market capitalization of roughly $22.26 billion based on Tuesday's closing price of $99.28.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
October 23, 2019 09:04 ET (13:04 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Alexion Pharmaceuticals Chart |
1 Month Alexion Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
